Merchant buys into biotech boom with $250m fund

PERTH: It’s been a biotech bonanza in the local funding market, with a ... read more

KKR Health clinics stoush heats up in court action

SYDNEY: It says a lot about a company’s culture when almost half its ... read more

Mesoblast pain drug agreement downgraded by German partner

MELBOURNE: Mesoblast and its German pharmaceutical partner Grünenthal have downgraded their collaboration agreement ... read more

Imugene shares soar on US breast cancer trial

MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning ... read more